ETF comparison

IBB vs VHT

Both Healthcare.

iShares Biotechnology ETF · Vanguard Health Care Index Fund ETF Shares

Holdings overlap

Weighted by ISIN/CUSIP
17.5 %

178 positions appear in both funds. Buying equal dollars of IBB and VHT would leave roughly 17.5% of each dollar exposed to the same underlying securities.

IBB only 92.2% Shared 17.5% VHT only 82.2%
In IBB only
78 positions
Shared
178 positions
In VHT only
230 positions

Side by side

IBB

iShares Biotechnology ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.44%
Net assets
$9.09B
TTM yield
0.22%
Top-10 conc.
54.7%
VHT

Vanguard Health Care Index Fund ETF Shares

Vanguard · Healthcare

84 composite / 100
Expense ratio
0.090%
Net assets
$20.39B
TTM yield
1.58%
Top-10 conc.
50.3%

Sub-score comparison

56
Cost
91
85
Tax efficiency
82
98
Liquidity
100
36
Concentration
42
Tracking quality
IBB sub-score VHT

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

VHT is 35 bps cheaper than IBB. On a $100,000 position that's about $350/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs VHT.

Top shared holdings

178 shared in total
# Holding In IBB In VHT Overlap
1 Amgen, Inc. 7.51% 3.10% 3.10%
2 Gilead Sciences, Inc. 7.75% 2.74% 2.74%
3 Vertex Pharmaceuticals, Inc. 7.44% 1.89% 1.89%
4 Regeneron Pharmaceuticals, Inc. 7.21% 1.21% 1.21%
5 Alnylam Pharmaceuticals, Inc. 3.99% 0.65% 0.65%
6 Insmed, Inc. 3.20% 0.47% 0.47%
7 Biogen, Inc. 2.46% 0.42% 0.42%
8 Natera, Inc. 2.41% 0.40% 0.40%
9 United Therapeutics Corp. 2.30% 0.32% 0.32%
10 Illumina, Inc. 1.68% 0.31% 0.31%
11 Incyte Corp. 1.70% 0.25% 0.25%
12 Moderna, Inc. 1.68% 0.24% 0.24%

Only in IBB

78 total
  • BlackRock Funds III 9.66%
  • Argenx SE 3.07%
  • BeOne Medicines Ltd. 1.93%
  • Genmab A/S 1.17%
  • Ascendis Pharma A/S 0.96%
  • BioNTech SE 0.66%
  • Abivax SA 0.50%
  • Xenon Pharmaceuticals, Inc. 0.43%
  • CRISPR Therapeutics AG 0.39%
  • Centessa Pharmaceuticals plc 0.25%

Only in VHT

230 total
  • Eli Lilly & Co 12.54%
  • Johnson & Johnson 8.74%
  • AbbVie Inc 6.08%
  • Merck & Co Inc 4.58%
  • UnitedHealth Group Inc 3.94%
  • Abbott Laboratories 3.00%
  • Thermo Fisher Scientific Inc 2.92%
  • Intuitive Surgical Inc 2.68%
  • Pfizer Inc 2.33%
  • Danaher Corp 2.01%

Open IBB or VHT at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.